SSM Health goes live with Surescripts National Record Locator Services
NRLS allows health clinicians to locate patient records no matter where they were previously treated. Read More »
NRLS allows health clinicians to locate patient records no matter where they were previously treated. Read More »
Outlines steps to reduce opioid use and treat substance abuse as a chronic disease. Read More »
New safety and efficiency data included on labels after EAGLES clinical trial. Read More »
ExtraCare Rewards members can select digital receipts for in-store purchases. Read More »
IBS-DonTract.com provides information and support to patients with IBS-D. Read More »
NACDS evaluating how increased access to Hepatitis C and HIV testing increases patient screenings. Read More »
Phase III study in Japan shows positive results in participants with advanced lung cancer. Read More »
More than 40 states have joined NABP PMP InterConnect to reduce prescription drug abuse. Read More »
Online program supports cystic fibrosis patients, caregivers and others affected by the disease. Read More »
Cigna Corp. may receive additional price discounts from pharmaceutical companies should new cholesterol medications prove less effective than expected — a move marks a crucial step in a broader initiative to link the cost of medications to their efficacy. Read More »
A new law in Indiana gives pharmacists the freedom of judgment to determine whether to dispense decongestants in an effort to interrupt the supply chain that produces methamphetamines Read More »
Maine Gov. Paul R. LePage recently signed into law a new state law that limits the doses, duration, and overall prescription of opioid therapies. Read More »
CVS Pharmacy recently opened a location in New Orleans Lower Ninth Ward, making it the first major retailer to establish a location in that area since Hurricane Katrina. Read More »
In recognition of May being Stroke Awareness Month, Prime Therapeutics LLC noted recently the importance medication plays in preventing strokes. Read More »
Fourteen presentations will present results of avelumab treatments for seven different cancer types. Read More »
Targeted treatment with Tecentriq approved; it is the first PD-L1 inhibitor approved by FDA for urothelial carcinoma. Read More »
Pfizer will showcase its growing portfolio of innovative treatments for a variety of cancers. Read More »
Updates on CVS Health's goals and initiatives for 2015 presented. Read More »
Communication key to developing treatment goals and disease management plan. Read More »
Four posters on nebivolol and fixed-dose combination of nebivolol and valsartan were presented. Read More »